Sumitomo Mitsui Trust Group
AZN icon

Sumitomo Mitsui Trust Group’s AstraZeneca AZN Stock Holding History

Sumitomo Mitsui Trust Group’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-50,914
Closed -$9.36M – 1052
2025
Q4 		$9.36M Buy
50,914
+3,056
+6% +$536K 0.01% 684
2025
Q3 		$7.34M Sell
47,858
-8,800
-16% -$1.33M ﹤0.01% 700
2025
Q2 		$7.92M Buy
56,658
+7,647
+16% +$1.07M ﹤0.01% 688
2025
Q1 		$7.2M Buy
49,011
+6,447
+15% +$933K 0.01% 710
2024
Q4 		$5.58M Buy
42,564
+308
+0.7% +$43.1K ﹤0.01% 736
2024
Q3 		$6.58M Buy
42,256
+4,898
+13% +$791K ﹤0.01% 741
2024
Q2 		$5.83M Sell
37,358
-2,079
-5% -$313K ﹤0.01% 743
2024
Q1 		$5.34M Buy
39,437
+6,687
+20% +$885K ﹤0.01% 815
2023
Q4 		$4.41M Sell
32,750
-42
-0.1% -$5.46K ﹤0.01% 825
2023
Q3 		$4.44M Buy
32,792
+6,124
+23% +$836K ﹤0.01% 837
2023
Q2 		$3.82M Sell
26,668
-5,054
-16% -$744K ﹤0.01% 856
2023
Q1 		$4.4M Buy
31,722
+185
+0.6% +$24.9K ﹤0.01% 844
2022
Q4 		$4.28M Buy
31,537
+2,696
+9% +$338K ﹤0.01% 854
2022
Q3 		$3.16M Sell
28,841
-951
-3% -$121K ﹤0.01% 900
2022
Q2 		$3.94M Buy
29,792
+337
+1% +$44.2K ﹤0.01% 884
2022
Q1 		$3.91M Buy
29,455
+12,685
+76% +$1.52M ﹤0.01% 882
2021
Q4 		$1.95M Sell
16,770
-1,710
-9% -$201K ﹤0.01% 946
2021
Q3 		$2.22M Sell
18,480
-140
-0.8% -$16.3K ﹤0.01% 938
2021
Q2 		$2.23M Buy
18,620
+4,274
+30% +$469K ﹤0.01% 943
2021
Q1 		$1.43M Buy
+14,346
New +$1.44M ﹤0.01% 971

Other funds holding AZN

IA
Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VAM
Vanguard Asset Management London, Ec4n 8af $117B AUM

Sumitomo Mitsui Trust Group's AZN Position: Q1 2026 in Review

Sumitomo Mitsui Trust Group sold out of AstraZeneca (AZN) in Q1 2026, closing a stake of 50,914 shares — an estimated $9.36M sold.

Sumitomo Mitsui Trust Group first reported a position in AZN in Q1 2021 and held it in 20 quarters. The position peaked at $9.36M in Q4 2025. 1,377 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

  • Sumitomo Mitsui Trust Group reported no remaining AstraZeneca position as of Q1 2026 after selling out during the quarter.
  • Sumitomo Mitsui Trust Group sold 50,914 AstraZeneca shares in Q1 2026, an estimated $9.36M.
  • Sumitomo Mitsui Trust Group first reported a position in AstraZeneca in Q1 2021 and held it in 20 quarters.
  • Sumitomo Mitsui Trust Group's AstraZeneca position peaked at $9.36M in Q4 2025.
  • 1,377 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on Sumitomo Mitsui Trust Group's 13F filing for Q1 2026, filed 30 Apr 2026.